Innovation by USound Enables Advanced Health Monitoring in TWS Earphones

Innovation by USound Enables Advanced Health Monitoring in TWS Earphones USound, a global leader in Micro Electronic Mechanical Systems (MEMS) speakers, has unveiled a groundbreaking innovation that will enable true wireless systems (TWS) earphones to feature advanced health monitoring capabilities…

Read MoreInnovation by USound Enables Advanced Health Monitoring in TWS Earphones

Vaccines Development: Vaxxas and CEPI Advance $4.8M Program for Needle-Free mRNA

Vaccines Development: Vaxxas and CEPI Advance $4.8M Program for Needle-Free mRNA Vaxxas, a clinical-stage biotechnology company focused on commercializing its innovative high-density microarray patch (HD-MAP) vaccination platform, today announced that the Coalition for Epidemic Preparedness Innovations (CEPI) has approved the…

Read MoreVaccines Development: Vaxxas and CEPI Advance $4.8M Program for Needle-Free mRNA

Collaboration Announced Between Simulations Plus and ETC for GastroPlus®

Collaboration Announced Between Simulations Plus and ETC for GastroPlus® Simulations Plus, Inc. (Nasdaq: SLP), a leader in biosimulation and performance solutions for the biopharma industry, has entered into an exciting new collaboration with the Enabling Technologies Consortium (ETC). This funded…

Read MoreCollaboration Announced Between Simulations Plus and ETC for GastroPlus®

Pancreatic Cancer Subtypes Unveiled by BPGbio at ASCO GI 2025 for Tailored Treatment

Pancreatic Cancer Subtypes Unveiled by BPGbio at ASCO GI 2025 for Tailored Treatment BPGbio, Inc., a clinical-stage biopharma company specializing in mitochondrial biology and protein homeostasis, today revealed new findings in pancreatic cancer subtyping from its long-term Project Survival® (NCT2781012)…

Read MorePancreatic Cancer Subtypes Unveiled by BPGbio at ASCO GI 2025 for Tailored Treatment

VSee Health Announces $935K Contracts with Leading Medical Device Manufacturers

VSee Health Announces $935K Contracts with Leading Medical Device Manufacturers VSee Health, Inc. (Nasdaq: VSEE), a leading provider of comprehensive digital health services and tailored telehealth workflows, has secured contracts totaling approximately $935,000 with several prominent medical technology solution companies.…

Read MoreVSee Health Announces $935K Contracts with Leading Medical Device Manufacturers

Charles River Expands Apollo™ Ecosystem with Custom Client Experiences

Charles River Expands Apollo™ Ecosystem with Custom Client Experiences Charles River Laboratories International, Inc. (NYSE: CRL) today introduced Apollo™ for CRADL®, a secure cloud-based platform designed to enhance its vivarium rental services. This digital platform connects clients effortlessly with the…

Read MoreCharles River Expands Apollo™ Ecosystem with Custom Client Experiences

Symposium 2025: Pulse Biosciences Presents Nanosecond PFA 360° Data

Symposium 2025: Pulse Biosciences Presents Nanosecond PFA 360° Data Pulse Biosciences, Inc. (Nasdaq: PLSE), a company utilizing its innovative Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, announced today the late-breaking data from its first-in-human feasibility study of the Nanosecond PFA 360°…

Read MoreSymposium 2025: Pulse Biosciences Presents Nanosecond PFA 360° Data

Congress 2025: United Therapeutics to Present Clinical Data at PVRI Annual Event

Congress 2025: United Therapeutics to Present Clinical Data at PVRI Annual Event United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that it will present five posters showcasing data from its commercial and development portfolio in pulmonary hypertension…

Read MoreCongress 2025: United Therapeutics to Present Clinical Data at PVRI Annual Event